Clinical trial
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
NCT07477639
Study timeline
Study start (actual)2026-03-01Date precision: day
Registry last updated2026-09-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Primary Progressive Multiple Sclerosisunresolved
Multiple Sclerosisunresolved
Interventions
TRX319BIOLOGICAL
BendamustineDRUG · verified · RxNorm: bendamustine
Sponsors & collaborators
Tr1X, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07477639 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.